WHO/Malin Bring
© Credits

Measles and rubella

    Overview

    Measles is a highly infectious virus and globally one of the leading causes of childhood mortality. It is transmitted person-to-person via droplets when infected people sneeze or cough. Initial symptoms usually occur 10–12 days after infection and comprise high fever, runny nose, bloodshot eyes and tiny white spots on the inside of the mouth. Several days later, a rash develops on the face and neck, and will gradually spread downwards. The most severe complications of measles include blindness, encephalitis (an infection that causes brain swelling), severe diarrhea, and pneumonia, among others.

    Rubella is usually mild when experienced in childhood and adolescence, but it can often lead to serious and even fatal complications for the foetus when an unprotected woman is infected in her early pregnancy. An infection during pregnancy can result in miscarriage or congenital defects in the unborn child, including hearing deficiency, eye and heart defects and other lifelong disabilities, such as autism, diabetes mellitus and thyroid dysfunction. Rubella is transmitted in airborne droplets from the nose, mouth or throat of infected people.

    Impact
    Measles and rubella infections are preventable through immunization. All countries in the WHO European Region have integrated highly effective and safe measles- and rubella-containing vaccines in their routine immunization programmes. Despite this, due to persistent gaps in immunization coverage, measles and rubella outbreaks continue to appear.
    WHO response
    All Member states in the Region have committed to the goal of eliminating measles and rubella as laid out by the European Vaccine Action Plan. WHO/Europe provides technical support to Member States to ensure full implementation of the Plan.

    Multimedia

    All →

    Our work

    All →

    Publications

    All →
    Programmatic considerations on identifying, addressing and monitoring immunization inequities in the WHO European Region

    This document provides step-by-step operational guidance following the WHO Regional Office for Europe publication A practical guide to identifying, addressing...

    Twenty-third Meeting of the European Technical Advisory Group of Experts on Immunization (‎ETAGE)‎: hybrid meeting, hosted in Copenhagen, Denmark, 5–6 December 2023

    The twenty-third meeting of the European Technical Advisory Group of Experts on Immunization (‎ETAGE)‎ was held in a hybrid format in Copenhagen,...

    Documents

    All →

    Data as of 30 September 2024 

    Epidata cover thumbnail
    6 August 2024

    EpiData 7/2024

    A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region.Reported measles cases for the period...